Haemonetics Corporation (HAE)

Haemonetics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Cash & Equivalents	260.71	245.44	306.76	178.8	284.47	259.5
Trading Asset Securities	2.2	0.82	1.31	1.67	1.11	-
Cash & Short-Term Investments	262.91	246.26	308.07	180.47	285.58	259.5
Cash Growth	-11.50%	-20.06%	70.70%	-36.80%	10.05%	34.94%
Receivables	224.95	216.86	202.66	206.56	179.14	159.38
Inventory	305.01	306.37	365.14	317.2	259.38	293.03
Prepaid Expenses	61.87	63.82	58.83	63.16	43.92	40.9
Other Current Assets	0.78	1.58	0.28	1.51	1.7	3.23
Total Current Assets	855.53	834.88	934.98	768.9	769.72	756.03
Property, Plant & Equipment	307.92	345.38	331.54	366.63	364.3	311.23
Long-Term Investments	27.23	0.95	1.02	0.06	-	-
Goodwill	657.1	656.37	604.27	565.08	466.23	467.29
Other Intangible Assets	426.36	510.06	499.74	429.02	275.77	310.26
Long-Term Deferred Tax Assets	9.35	9.52	7.8	7.74	5.24	4.47
Other Long-Term Assets	127.11	38.78	71.59	58.16	53.56	10.46
Total Assets	2,411	2,396	2,451	2,196	1,935	1,860

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Accounts Payable	71.64	51.06	67	73.36	63.93	58.37
Accrued Expenses	54.42	68.19	59.42	80.71	64.48	48.54
Current Portion of Long-Term Debt	9.64	5.02	303.56	10.23	11.78	215.96
Current Portion of Leases	-	9.24	8.11	8.13	7.16	7.2
Current Unearned Revenue	67.3	42.31	43.35	31.24	30.21	26.81
Other Current Liabilities	97.83	106.78	96.68	96.71	74.26	85.39
Total Current Liabilities	300.84	282.6	578.11	300.38	251.82	442.27
Long-Term Debt	1,114	1,220	921.23	797.56	755.91	559.44
Long-Term Leases	-	40.9	50.45	57.96	55.9	55.7
Long-Term Deferred Tax Liabilities	41.82	38.05	62.58	62.64	36.2	28.73
Other Long-Term Liabilities	55.33	18.5	17.74	17.08	17.01	24.17
Total Liabilities	1,512	1,600	1,630	1,236	1,117	1,110

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Common Stock	0.46	0.45	0.48	0.51	0.5	0.51
Additional Paid-In Capital	579.8	554.14	523.26	634.63	594.71	572.48
Retained Earnings	356.96	279.34	352.17	360.46	253.17	202.39
Comprehensive Income & Other	-38.72	-37.61	-55.08	-35.63	-30.38	-25.95
Shareholders' Equity	898.5	796.32	820.84	959.96	818	749.42
Total Liabilities & Equity	2,411	2,396	2,451	2,196	1,935	1,860

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Total Debt	1,124	1,275	1,283	873.88	830.76	838.3
Net Cash (Debt)	-860.85	-1,028	-975.28	-693.41	-545.18	-578.81
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-18.56	-21.72	-19.22	-13.49	-10.60	-11.27
Filing Date Shares Outstanding	45.54	45.45	48.04	50.84	50.54	51.28
Total Common Shares Outstanding	45.52	45.25	48.22	50.79	50.45	51.12
Working Capital	554.69	552.28	356.86	468.52	517.91	313.77
Book Value Per Share	19.74	17.60	17.02	18.90	16.21	14.66
Tangible Book Value	-184.97	-370.1	-283.18	-34.14	76	-28.12
Tangible Book Value Per Share	-4.06	-8.18	-5.87	-0.67	1.51	-0.55
Land	2.29	2.25	1.99	4.13	5.36	5.17
Buildings	109.76	109.79	105.08	124.34	127.63	104.36
Machinery	724.27	699.84	707.9	791.02	781.86	706.01
Construction In Progress	37	29.94	22.23	39.69	29.37	53.61

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error